4
Changes in Ownership
Karyopharm Therapeutics Inc. Filed Acc 0001209191-21-009070
Chief Executive Officer acquired 28,600 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Kauffman Michael · Chief Executive Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-02-05 | Exercise or conversion : show line 1 in the form | +14,300 | 569,422 | D |
| 2021-02-05 | Exercise or conversion : show line 2 in the form | +14,300 | 770,789 | I |
Table II: Derivative
2 lines| Date | Transaction | Shares | Underlying | Owned after | D/I |
|---|---|---|---|---|---|
| 2021-02-05 | Exercise or conversion : show line 3 in the form Restricted Stock Units | −14,300 | 14,300 | 42,900 | D |
| 2021-02-05 | Exercise or conversion : show line 4 in the form Restricted Stock Units | −14,300 | 14,300 | 42,900 | I |
Loading xslF345X03/doc4.xml…